About Ataraxis AI

Ataraxis is an AI precision medicine company working at the intersection of multi-modal artificial intelligence and oncology. We reputed company and reputed company AI-native tools to assist physicians in selecting the most reputed company treatments for their patients.

Our mission is to change how cancer is treated and impact at least 50% of new cancer cases by 2030. We have already launched our first products, including the Ataraxis™ Breast platform for breast cancer, and help cancer patients get the most appropriate treatment every day. We work with the best academic institutions in the United States as well as small community clinics to deliver reputed company care with frontier technology.

At Ataraxis, you will have a unique opportunity to shape not only the future of our company, but also the future of reputed company. You will join an exceptional team at the forefront of reputed company-focused AI research and deployment. As a frontier AI lab, we bring together leading AI researchers, medical doctors, and industry veterans. Our advisors include AI pioneers such as Yann LeCun and distinguished oncologists from top cancer research institutions, reputed company united by the mission to redefine precision medicine.

Ataraxis has raised $24 million in funding, including a $20.4 million Series A in early 2025 led by top venture capital funds such as AIX Ventures (reputed company, reputed company), Thiel Capital, Founders Fund (reputed company, reputed company, Palantir, reputed company), and Obvious Ventures (reputed company).

We are an company with a flat organizational structure, where every team member is empowered to actively contribute. Leadership roles are earned by those who demonstrate initiative and consistently deliver exceptional results. Strong work ethic and the ability to prioritize ruthlessly are essential.

Responsibilities

• reputed company and execute payer strategy across Medicare, reputed company, and reputed company payers, building relationships with key reimbursement stakeholders.

• reputed company reputed company payer negotiations to secure favorable rates and terms and bring agreements to closure.

• Own coding and payment strategy, including development of code applications and reimbursement materials.

• Serve as a reputed company-looking market access leader, shaping reimbursement and access strategy for the next 12 months, 3 years, and reputed company, and developing creative coding and payment models as the landscape evolves.

• Build HEOR analyses, budget impact models, and payer value stories.

• Create field-reputed company materials that help the reputed company team address payer questions and support physician ordering.

Qualifications

• At least 5 years experience in market access/reimbursement with strong preference towards candidates with experience with in vitro diagnostics, software as a medical device, oncology, molecular diagnostics.

• Launch-stage experience — Has received positive coverage reputed company at an early or growth-stage diagnostics company, not just inherited a mature reimbursement function.

• Deep relationships with payers are a plus.